Developing an HbA1c-Based Equation to Estimate Blood Glucose in Maintenance Hemodialysis Patients

OBJECTIVE Hemoglobin A1c (HbA1c) has been widely used as a clinically important assessment tool for outcome analyses related to glycemic control. However, because of special conditions in dialysis patients, including the uremic milieu, there is no HbA1c blood glucose (BG) equation specific for patients on dialysis. In this study, we sought to develop HbA1c-BG equation models for hemodialysis patients. RESEARCH DESIGN AND METHODS We examined associations between HbA1c and random serum BG over time in a contemporary cohort of diabetic patients with hemodialysis treated in DaVita dialysis clinics. We identified 11,986 patients (63 ± 12 years old and 49% male) with 69,764 paired measurements of HbA1c and BG over the course of 5 years (2001–2006). Bootstrapping method was used to estimate average BG and corresponding HbA1c levels. The association was adjusted by patient factors using linear regression. RESULTS Linear regression analyses yielded the following three regression equations: BG = 59.2 + 29.4 × HbA1c − 20.8 × Alb (R2 = 0.483); BG = 104.8 + 29.7 × HbA1c − 18.4 × Alb − 4.7 × Hb (R2 = 0.486); and BG = 82.9 + 30.7 × HbA1c − 16.5 × Alb − 5.4 × Hb + 0.3 × age + race (R2 = 0.491). All our models showed stronger association than previous equation models (R2 = 0.468 in the Diabetes Control and Complications Trial and A1c-Derived Average Glucose equations). CONCLUSIONS The association between HbA1c and BG in hemodialysis patients is different than that of patients with normal kidney function. Our analysis suggests that equations including serum albumin or hemoglobin are better for hemodialysis patients.

[1]  M. Emoto,et al.  Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  Kazuhiko Kawahara,et al.  Stringent glycaemic control prolongs survival in diabetic patients with end‐stage renal disease on haemodialysis , 2010, Nephrology.

[3]  B. Freedman,et al.  Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. , 2008, Kidney international.

[4]  K. Kalantar-Zadeh,et al.  Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. , 2010, Kidney international. Supplement.

[5]  K. Park,et al.  Analysis of hemodialysis-associated hypoglycemia in patients with type 2 diabetes using a continuous glucose monitoring system. , 2010, Diabetes technology & therapeutics.

[6]  D. Raj,et al.  Hypercatabolism in dialysis patients , 2008, Current opinion in nephrology and hypertension.

[7]  M. Rocco,et al.  Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[8]  D. Goldstein,et al.  Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.

[9]  T. Uzu,et al.  Target for Glycemic Control in Type 2 Diabetic Patients on Hemodialysis: Effects of Anemia and Erythropoietin Injection on Hemoglobin A1c , 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[10]  K. Kalantar-Zadeh,et al.  Association of Pretransplant Glycemic Control With Posttransplant Outcomes in Diabetic Kidney Transplant Recipients , 2011, Diabetes Care.

[11]  S. Greenland,et al.  Association of hemodialysis treatment time and dose with mortality and the role of race and sex. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  K. Kalantar-Zadeh,et al.  Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  K. Kalantar-Zadeh,et al.  Glycemic Control and Burnt‐Out Diabetes in ESRD , 2010, Seminars in dialysis.

[14]  S. Anker,et al.  The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. , 2010, Mayo Clinic proceedings.

[15]  D. Schoenfeld,et al.  Translating the A1C Assay Into Estimated Average Glucose Values , 2008, Diabetes Care.

[16]  J. Bargman,et al.  Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus , 2012, International Urology and Nephrology.

[17]  Keith C. Norris,et al.  Association of Cumulatively Low or High Serum Calcium Levels with Mortality in Long-Term Hemodialysis Patients , 2010, American Journal of Nephrology.

[18]  S. E. Park,et al.  Serum 1,5-Anhydroglucitol Concentrations Are a Reliable Index of Glycemic Control in Type 2 Diabetes With Mild or Moderate Renal Dysfunction , 2012, Diabetes Care.